Pancancer analyses reveal genomics and clinical characteristics of the SETDB1 in human tumors

X Lin, M Xiao, Z Chen, C Ding, T Zhang… - Journal of …, 2022 - Wiley Online Library
Background. Malignant tumor is one of the most common diseases that seriously affect
human health. The prior literature has reported the biological function and potential …

Histone lysine methyltransferase SETDB2 suppresses NRF2 to restrict tumor progression and modulates chemotherapy sensitivity in lung adenocarcinoma

G Yuan, B Hu, J Ma, C Zhang, H Xie, T Wei… - Cancer …, 2023 - Wiley Online Library
Objective Aberrant epigenetic remodeling represents a molecular hallmark in lung
adenocarcinoma (LUAD). We aim to investigate the biological roles of SETDB2 and its …

[HTML][HTML] tRNA-derived small RNAs in human cancers: roles, mechanisms, and clinical application

M Zhou, X He, J Zhang, C Mei, B Zhong, C Ou - Molecular Cancer, 2024 - Springer
Transfer RNA (tRNA)-derived small RNAs (tsRNAs) are a new type of non-coding RNAs
(ncRNAs) produced by the specific cleavage of precursor or mature tRNAs. tsRNAs are …

[HTML][HTML] Novel epigenetic eight-gene signature predictive of poor prognosis and MSI-like phenotype in human metastatic colorectal carcinomas

V Condelli, G Calice, A Cassano, M Basso… - Cancers, 2021 - mdpi.com
Simple Summary The global methylation profile of two human metastatic colorectal
carcinoma subgroups with significantly different outcomes (primary-resistant versus drug …

[HTML][HTML] Epigenetic regulation and therapeutic targets in the tumor microenvironment

Z Xie, Z Zhou, S Yang, S Zhang, B Shao - Molecular Biomedicine, 2023 - Springer
The tumor microenvironment (TME) is crucial to neoplastic processes, fostering proliferation,
angiogenesis and metastasis. Epigenetic regulations, primarily including DNA and RNA …

[HTML][HTML] Is there a role for epigenetic therapies in modulating DNA damage repair pathways to enhance chemotherapy and overcome drug resistance?

IM Garner, R Brown - Cancers, 2022 - mdpi.com
Simple Summary Epigenetic changes in a cell's genome can cause the inactivation of genes
and affect how tumours respond to chemotherapy. These epigenetic changes do not alter …

[HTML][HTML] Epigenetic modification in diabetic kidney disease

Z Liu, J Liu, W Wang, X An, L Luo, D Yu… - Frontiers in …, 2023 - frontiersin.org
Diabetic kidney disease (DKD) is a common microangiopathy in diabetic patients and the
main cause of death in diabetic patients. The main manifestations of DKD are proteinuria …

[HTML][HTML] Harnessing bioluminescence for drug discovery and epigenetic research

HJ Gleneadie, A Dimond, AG Fisher - Frontiers in Drug Discovery, 2023 - frontiersin.org
The naturally occurring phenomenon of bioluminescence has intrigued on-lookers for
decades and is now being developed as a powerful tool for medical research and preclinical …

tRNA modifications and their potential roles in pancreatic cancer

H Huang, H Li, R Pan, S Wang, X Liu - Archives of Biochemistry and …, 2021 - Elsevier
Since the breakthrough discovery of N6-methyladenosine (m 6 A), the field of RNA
epitranscriptomics has attracted increasing interest in the biological sciences. Transfer …

N6‐methyladenosine methylation regulatory pattern of pulmonary lymphoepithelioma‐like carcinoma based on exosomal transcriptome analysis

M Yu, Y Pan, H Li, X Liu, Z Chen, H Chen… - Molecular …, 2023 - Wiley Online Library
Pulmonary lymphoepithelioma‐like carcinoma (pLELC) is a rare malignancy that lacks
specific biomarkers. N6‐methyladenosine (m6A) is the most widespread internal …